Mahamaya Lifesciences IPO Will Open On Nov 11, 2025 And Close On Nov 13, 2025. The ₹70.44 Cr. IPO is A Fresh Issue and Offer for Sale. Mahamaya Lifesciences IPO Price Band is Set At ₹108 to ₹114 Per share.
The Allotment Will Be Finalized On Nov 14, 2025 and Listing date is Expected on The BSE SME By Nov 18, 2025. Investor Quota like 33.33% Retail 14.27% HNI 47.39% QIB and Market Maker is 5.01% Category.
Financial Year 2025 Company Posted a total income ₹267.17 Cr. and A Net Profit of ₹12.94 Cr. Showing Strong Growth From The Previous Year. Based On Financial, The IPO Looks Promising For Long-term Investors.
Mahamaya Lifesciences IPO Dates & Price Band Details
| Open Date | Nov 11, 2025 |
|---|---|
| Close Date | Nov 13, 2025 |
| Price Band | ₹108 to ₹114 per share |
| Face Value | ₹10 per equity share |
| Lot Size | 1,200 Shares |
| Type of Issue | Fresh Issue and OFS |
| Total Issue Size | 61,78,800 shares (Approx ₹70.44 Cr) |
| Market Maker | 3,09,600 shares (Approx ₹3.35 Cr) |
| Fresh Issue | 53,29,200 shares (Approx ₹60.75 Cr) |
| Offer for Sale | 5,40,000 shares (Approx ₹6.16 Cr) |
| Net Issue to the Public | 58,69,200 shares (Approx ₹66.91 Cr) |
| Issue Type | Bookbuilding IPO |
| Listing Exchange | BSE SME |
| QIB Quota | 47.39% |
| Retail Investor Quota | 33.33% |
| NII (HNI) Quota | 14.27% |
| Market Maker | 5.01% |
| Anchor Investor List | Click Here |
| DRHP (Draft Prospectus) | Click Here |
| RHP (Final Prospectus) | Click Here |
About Mahamaya Lifesciences Limited
Our Company was originally incorporated on May 07, 2002 “Mahamaya Lifesciences Limited” Our company specializes in the manufacturing of pesticide formulations and supply bulk formulations catering to both Indian agrochemical companies, as well as multinational corporations (MNCs).
- Crop Protection
- Household Pesticides
- Plant Nutrition
- Speciality Chemicals
We began our journey by focusing on import and registration of vital pesticide molecules (Technical) that were not produced domestically in India. We imported these molecules after lot of product research and worked on registering them with the Central Insecticides Board and Registration Committee (CIBRC) under the Department of Agriculture, Government of India. After successful registration we marketed these molecules both as technical and as value added end use formulations for both domestic manufacturers and MNCs.
we produce and sell bulk formulations, branded products (own brand products), and export them to customers. Domestically, we market our own branded products across states such as Punjab, Haryana, Rajasthan, Uttar Pradesh, Gujarat, Maharashtra, Andhra Pradesh, and
Telangana through a well-established dealer network.
Internationally we export our products to countries including the Dominican Republic, Turkey, Egypt, and the UAE, ensuring full adherence to all manufacturing and compliance standards.
Our Competitive Strengths
Experienced management team consisting of experts.
Capability to introduce vital products for Indian Agriculture.
Development of export opportunities of products.
Ability to develop brands.
Cordial relationships with suppliers of raw materials.
Core values focused on achieving sustainability through innovative approaches.
Mahamaya Lifesciences IPO Market Lot Size
The Minimum Lot Size For The Mahamaya Lifesciences IPO is 1,200 Shares, Requiring An Application Amount of ₹2,73,600 and in multiples of 2,400 For Retail Investors. Investors Must Apply in Multiples of The Lot Size.
| Application | Lot Size | Shares | Amount |
|---|---|---|---|
| Retail Minimum | 2 | 2,400 | ₹2,73,600 |
| Retail Maximum | 2 | 2,400 | ₹2,73,600 |
| S-HNI Minimum | 3 | 3,600 | ₹4,10,400 |
| S-HNI Maxmum | 7 | 8,400 | ₹9,57,600 |
| B-HNI Minimum | 8 | 9,600 | ₹10,94,400 |
Objects Of The Issue
- Purchase of Equipment for existing Formulation plant.
- Funding capital expenditure towards setting up of a new technical manufacturing plant.
- Construction of Warehouse Building and Purchase of Machinery.
- Funding working capital requirement of our Company.
- General Corporate purposes.
Mahamaya Lifesciences IPO Allotment & Listing Date
Mahamaya Lifesciences IPO Will Open on Nov 11 and Close on Nov 13, 2025. The allotment is Expected on Nov 14, With the Listing Scheduled on BSE SME For Nov 18, 2025 (More information below table).
| IPO Open | Tue, Nov 11, 2025 |
|---|---|
| IPO Close | Thu, Nov 13, 2025 |
| Allotment Finalisation | Fri, Nov 14, 2025 |
| Refunds / Unblocking | Mon, Nov 17, 2025 |
| Shares Credited to Demat | Mon, Nov 17, 2025 |
| Listing Date | Tue, Nov 18, 2025 |
Mahamaya Lifesciences IPO Financial Report (FY 2025)
Mahamaya Lifesciences Reported a Total Income of ₹267.17 Cr. in FY 2025, Slightly up From ₹162.83 Cr. in FY 2024. The Company Net Profit Also Rose to ₹12.94 Cr. From ₹5.22 Cr. in the Previous Year Showing Consistent Financial Growth Ahead of its IPO. (More information below table).
| Period Ended | 30 Jun 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 218.87 | 188.35 | 112.07 | 77.88 |
| Total Income | 84.04 | 267.17 | 162.83 | 137.40 |
| Profit After Tax | 4.10 | 12.94 | 5.22 | 3.75 |
| EBITDA | 8.04 | 24.64 | 13.36 | 8.91 |
| NET Worth | 53.50 | 49.42 | 24.66 | 19.44 |
| Reserves and Surplus | 35.73 | 31.66 | 23.41 | 18.19 |
| Total Borrowing | 57.72 | 58.11 | 54.63 | 24.37 |
| Amount in ₹ Crore |
Mahamaya Lifesciences IPO Valuation Report – FY 2025 (KPI)
Check Detailed Mahamaya Lifesciences IPO Valuation Metrics for FY 2025, including EPS, P/E Ratio, RoNW, NAV, ROCE, and other key financial indicators. These Ratios help Investors Assess the Company financial Health & Valuation Before applying for The IPO. (More information below table).
| KPI | Value |
|---|---|
| Return on Equity (ROE) | 34.94% |
| Return on Capital Employed (ROCE) | 23.15% |
| EBITDA Margin | 9.22% |
| PAT Margin | 4.84% |
| Debt-to-Equity Ratio | 1.08 |
| Earnings Per Share (EPS) | 7.29 |
| Price to Earnings Ratio (P/E) | 15.65 |
| Return on Net Worth (RoNW) | 26.19% |
| Net Asset Value (NAV) | 27.82 |
Our Company Promoters
Mr. Krishnamurthy Ganesan
Mrs. Lalitha Krishnamurthy
Mr. Prashant Krishnamurthy
Comparison of Accounting Ratios with Industry Peers
| Name of Company | Current Market Price (₹) | Face Value (₹) | EPS | PE Ratio | RoNW (%) | NAV per Share (₹) | Total Income (₹ in lakhs) |
|---|---|---|---|---|---|---|---|
| Mahamaya Lifesciences Limited | [●] | 10 | 7.60 | [●] | 26.19 | 27.82 | 26,717.31 |
| Nova Agritech Limited | 51.63 | 2 | 3.05 | 16.93 | 12.47 | 23.76 | 29,659.89 |
| Bhagiradha Chemicals & Industries Limited | 282.30 | 1 | 1.14 | 247.63 | 2.03 | 52.61 | 44,975.22 |
Also Read: Fujiyama Power Systems IPO GMP, Price, Date, Review, Details
Also Read: Workmates Core2Cloud IPO,Listing Price, GMP, Date, Review, Details
Mahamaya Lifesciences Company Contact Details
Mahamaya Lifesciences Ltd.
Unit No: DPT – 033, Ground Floor, Plot No: 79 – 80,
DLF Prime Tower,Block, Okhla, Phase – 1 Delhi,
New Delhi, 110020
Tel. No: +91-1146561474
Email: cs@mahamayalifesciences.com
Website: https://www.mahamayalifesciences.com/
Mahamaya Lifesciences Lead Manager
Oneview Corporate Advisors Pvt. Ltd.
The Summit Business Bay, 619 & 620, 6th Floor,
266/1-172, Gundavali, Andheri Kurla Road,
Andheri (East), Mumbai – 400 093
Tel. No: +91 – 22 – 6901 0381
Email: mbd@oneviewadvisors.com
Website: https://www.oneviewadvisors.com/
Mahamaya Lifesciences IPO Registrar
KFin Technologies Limited
Selenium Tower-BPlot No. 31 & 32,
Financial District Nanakramguda,
Serilingampally Hyderabad 500 032
Telangana, India
Tel: +91 40 6716 2222
E-mail: midwest.ipo@kfintech.com
Website: www.kfintech.com
Mahamaya Lifesciences IPO FAQs
Question 1: What is the Mahamaya Lifesciences IPO?
Answer 1: Mahamaya Lifesciences IPO is a SME IPO of 61,78,800 equity shares of the face value of ₹10 approximately up to ₹70.44 Cr. The issue is price at ₹108 to ₹114 per share.
The Mahamaya Lifesciences IPO opens on Nov 11, 2025 and closes on Nov 13, 2025.
KFin Technologies Limited LIMITED is the registrar for the IPO. The shares to be listed on BSE SME.
Question 2: How to apply in Mahamaya Lifesciences IPO through Groww?
Answer 2: Groww customers can apply online in Mahamaya Lifesciences IPO using UPI as a payment gateway. Groww customers can apply in Mahamaya Lifesciences IPO by login into Groww (back office) and submitting an IPO application form.
Steps to apply in Mahamaya Lifesciences IPO through Groww –
Visit the Groww website and login to Groww.
Go to Main Page and click the Products & tools and click IPO tab.
New page Open and Show ‘ Mahamaya Lifesciences IPO’ click the ‘Apply’ button.
Show IPO detail Shares lot Size and Bid Price & click here to Cutoff Price check Box and Continue.
Inter Your UPI id like . 95****299@kotak accept terms and condition click Box and Apply For IPO
groww share payment link Your UPI Mobile Number Pay Payment for IPO Bid to approve the e-mandate successfully submit application .
Question 3: When Mahamaya Lifesciences IPO will open?
Answer 3: The Mahamaya Lifesciences IPO opens on Nov 11, 2025 and closes on Nov 13, 2025.
Question 4: What is the lot size of Mahamaya Lifesciences IPO?
Answer 4: Mahamaya Lifesciences IPO lot size and the minimum order quantity is 1,200 Shares.
Question 5: How to apply for Mahamaya Lifesciences IPO?
Answer 5: You can apply in Mahamaya Lifesciences IPO online using either UPI or ASBA as a payment method. ASBA IPO application is available in the net banking of your bank account. UPI IPO application is offered by brokers who don’t offer banking services. Read more detail about applying IPO online through Groww, Zerodha, Upstox, 5Paisa, Phonepe Share Market, HDFC Bank, and Angel one.
Question 6: When is Mahamaya Lifesciences IPO allotment date?
Answer 6: The Basis of Allotment for Mahamaya Lifesciences IPO will be on Fri, Nov, 14, 2025, and the allotted shares will be credited to your demat account by Mon, Nov, 17, 2025. For Check the Mahamaya Lifesciences IPO allotment status.
Question 7: When is Mahamaya Lifesciences IPO listing date?
Answer 7: The Mahamaya Lifesciences IPO listing date is Nov 18, 2025. The date of Mahamaya Lifesciences IPO listing on Tue, Nov, 18, 2025.
